相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PD-L1 status in breast cancer: Current view and perspectives
Semir Vranic et al.
SEMINARS IN CANCER BIOLOGY (2021)
LncRNA UCA1 attenuated the killing effect of cytotoxic CD8+T cells on anaplastic thyroid carcinoma via miR-148a/PD-L1 pathway
Xiaoming Wang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Thalidomide suppresses angiogenesis and immune evasion via lncRNA FGD5-AS1/miR-454-3p/ZEB1 axis-mediated VEGFA expression and PD-1/PD-L1 checkpoint in NSCLC
Yang Xia et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2021)
LncRNA TINCR favors tumorigenesis via STAT3-TINCR-EGFR-feedback loop by recruiting DNMT1 and acting as a competing endogenous RNA in human breast cancer
Qin Wang et al.
CELL DEATH & DISEASE (2021)
SChLAP1 promotes prostate cancer development through interacting with EZH2 to mediate promoter methylation modification of multiple miRNAs of chromosome 5 with a DNMT3a-feedback loop
Kai Huang et al.
CELL DEATH & DISEASE (2021)
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
D. Miles et al.
ANNALS OF ONCOLOGY (2021)
LncRNA KCNQ1OT1 Secreted by Tumor Cell-Derived Exosomes Mediates Immune Escape in Colorectal Cancer by Regulating PD-L1 Ubiquitination via MiR-30a-5p/USP22
Di Xian et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Autophagy promotes citrullination of VIM (vimentin) and its interaction with major histocompatibility complex class II in synovial fibroblasts
Eri Sugawara et al.
AUTOPHAGY (2020)
PD-1/PD-L1 axis regulation in cancer therapy: The role of long non-coding RNAs and microRNAs
Milad Ashrafizadeh et al.
LIFE SCIENCES (2020)
Structure of the IFNγ receptor complex guides design of biased agonists
Juan L. Mendoza et al.
NATURE (2019)
Low-Dose IFNγ Induces Tumor Cell Stemness in Tumor Microenvironment of Non-Small Cell Lung Cancer
Mengjia Song et al.
CANCER RESEARCH (2019)
IFNγ-Induced IFIT5 Promotes Epithelial-to-Mesenchymal Transition in Prostate Cancer via miRNA Processing
U-Ging Lo et al.
CANCER RESEARCH (2019)
Subgroup analysis of Japanese patients in a Phase 3 study of atezolizumab in advanced triple-negative breast cancer (IMpassion130)
Hiroji Iwata et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2019)
PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer
Audrey Monneur et al.
BULLETIN DU CANCER (2018)
Long noncoding RNAs in cancer-immunity cycle
Wei-Di Yu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
IFN gamma-activated dermal lymphatic vessels inhibit cytotoxic T cells in melanoma and inflamed skin
Ryan S. Lane et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Transcriptome Analysis of Triple-Negative Breast Cancer Reveals an Integrated mRNA-lncRNA Signature with Predictive and Prognostic Value
Yi-Zhou Jiang et al.
CANCER RESEARCH (2016)
Suppression of microRNA activity amplifies IFN-γ-induced macrophage activation and promotes anti-tumour immunity
Caroline Baer et al.
NATURE CELL BIOLOGY (2016)
Anti-PD-L1 for metastatic triple-negative breast cancer
Josefine Gibson
LANCET ONCOLOGY (2015)
LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer
Sheng-Jia Shi et al.
ONCOTARGET (2015)
Immune Modulation in Cancer with Antibodies
David B. Page et al.
ANNUAL REVIEW OF MEDICINE, VOL 65 (2014)
Comprehensive analysis of long non-coding RNAs in human breast cancer clinical subtypes
Xiaoping Su et al.
ONCOTARGET (2014)
PD-L1 Expression in Triple-Negative Breast Cancer
Elizabeth A. Mittendorf et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer
Kristina P. Sorensen et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
RNA in unexpected places: long non-coding RNA functions in diverse cellular contexts
Sarah Geisler et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
PD-1 as a potential target in cancer therapy
David F. McDermott et al.
CANCER MEDICINE (2013)
A Long Noncoding RNA Controls Muscle Differentiation by Functioning as a Competing Endogenous RNA
Marcella Cesana et al.
CELL (2011)
Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses
Moran N. Cabili et al.
GENES & DEVELOPMENT (2011)
The Emergence of lncRNAs in Cancer Biology
John R. Prensner et al.
CANCER DISCOVERY (2011)
Combinatorial biomarker expression in breast cancer
Emad A. Rakha et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
Rajnish A. Gupta et al.
NATURE (2010)
CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer
Jiayi Wang et al.
NUCLEIC ACIDS RESEARCH (2010)
Responsiveness of Stromal Fibroblasts to IFN-γ Blocks Tumor Growth via Angiostasis
Yu Lu et al.
JOURNAL OF IMMUNOLOGY (2009)
PD-1 and PD-1 ligands: from discovery to clinical application
Taku Okazaki et al.
INTERNATIONAL IMMUNOLOGY (2007)
Sustained low-level expression of interferon-γ promotes tumor development:: potential insights in tumor prevention and tumor immunotherapy
YF He et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
HD Dong et al.
NATURE MEDICINE (2002)
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
GJ Freeman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
